AB Science
5 Avis
À propos de l'entreprise
AB Science is developing two main compounds | AB Science is currently developing two main compounds, masitinib, a highly selective tyrosine kinase inhibitor and AB8939.
Contacts
Site Web
Appelez-nous
+33147200014
3 Av. George V, 75008 Paris
Heures
Fonctionnalités
- Entrée accessible en fauteuil roulant
Avis recommandés
Marek L
19.11.2023
AB Science
This company doesnt pay their bills even to hospitals, people in this company have been changing every few month even project managers .. This company has zero credibility to do clinical research, they breached gcp in many of their clinical trials... Their clinical portfolio is outdated
Ajouter un avis
Carte
3 Av. George V, 75008 Paris
AB Science